Eurofins Buying ViraCor-IBT Labs for $255M | GenomeWeb

NEW YORK (GenomeWeb News) – Bioanalytical testing company Eurofins Scientific today said it has signed a definitive agreement to purchase esoteric reference laboratory ViraCor-IBT Laboratories for about $255 million.

Eurofins is purchasing VIBT from majority owner Ampersand Capital, a private equity firm, and other shareholders. The deal is anticipated to close within 60 days, Eurofins said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.